Glycogen synthase kinase (GSK)-3␤ may modulate endoplasmic reticulum (ER) stress-induced apoptosis; however, the mechanism remains unclear. Our data showed that human monocytic leukemia/lymphoma U937 and acute myeloid leukemia HL-60, but not chronic myeloid leukemia K562, cells were susceptible to apoptosis induced by ER stressor tunicamycin, a protein glycosylation inhibitor. Tunicamycin caused early activation of caspase-2, -3, -4, and -8, followed by apoptosis, whereas caspase-9 was slowly activated. Inhibiting caspase-2 reduced activation of caspase-8 and -3 but had no effect on caspase-4. Tunicamycin induced apoptosis independently of the mitochondrial pathway but caused lysosomal destabilization followed by lysosomal membrane permeabilization (LMP), cathepsin B relocation from lysosomes to the cytosol, and caspase-8 and -3 activation. It is notable that caspase-2 mediated lysosomal destabilization. Inhibiting GSK-3␤ comprehensively reduced lysosomal apoptosis after caspase-2 inhibition. Unlike U937 and HL-60 cells, K562 cells showed nonresponsive ER stress and failure of activation of GSK-3␤ and caspase-2 in response to tunicamycin. Activating GSK-3␤ caused K562 cells to be susceptible to tunicamycin-induced apoptosis. Taken together, we show that GSK-3␤ exhibits a mechanism of ER stress-induced lysosomal apoptosis in leukemia involving caspase-2-induced LMP and cathepsin B relocation, which result in caspase-8 and -3 activation.
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Leukemia is pathologically characterized by abnormal expansion of hematopoietic progenitor cells. Several drugs have been developed for therapeutic applications; however, leukemia remains problematic because of relapse and drug resistance. The proapoptotic action of antileukemic agents may act through the induction of endoplasmic reticulum (ER) stress (Du et al., 2006; Rahmani et al., 2007) . Therefore, cellular ER is a target for improved, selective anticancer therapies (Linder and Shoshan, 2005; Boelens et al., 2007) .
However, the molecular mechanism of ER stress-triggered apoptosis in leukemia remains unresolved.
The ER is the site of protein synthesis, modification, and folding. Multiple insults, such as inhibition of glycosylation, reduction of disulfide bonds, calcium depletion from the ER lumen, impairment of protein transport to the Golgi, and expression of mutated proteins in the ER, can trigger unfolded protein response (UPR) after ER stress (Wu and Kaufman, 2006) . These events enhance protein folding and degradation within the ER and down-regulate protein synthesis until cells have recovered from ER stress. However, prolonged ER stress may eventually cause apoptosis, whereas calcium homeostasis and UPR cannot be restored. In ER stress-induced apoptosis, several apoptotic signaling pathways are demonstrated (Breckenridge et al., 2003) . ER stress-induced CCAAT/enhancer-binding protein homolo-gous protein (CHOP/Gadd153), a transcription factor that suppresses the expression of antiapoptotic protein Bcl-2 and increases reactive oxygen species production, is involved in apoptosis through the mitochondrial pathway (McCullough et al., 2001) . ER stress-activated c-Jun NH 2 -terminal kinase is also involved (Tan et al., 2006) . Calpain, a calcium-dependent protease, generally causes activation of human caspase-4, a specific ER stress-activated caspase with 48% sequence homology to murine caspase-12 (Nakagawa and Yuan, 2000; Fischer et al., 2002) . It is notable that caspase-4 triggers apoptotic pathways dependent or independent of caspase-9 and -3 activation (Breckenridge et al., 2003) . Furthermore, activation of caspase-2, -3, -7, -8, and -9 also have been reported in ER stress-induced apoptosis (Dahmer, 2005; Cheung et al., 2006; Liu et al., 2006; Upton et al., 2008) . However, the role of caspase cascade activation is still controversial owing to differences in ER stressor stimulation and cell type dependence.
The lysosome, an acidic organelle, plays a pivotal role in apoptosis caused by various stimuli, including oxidative stress, tumor necrosis factor-␣, sphingosine, p53, and staurosporine (Ferri and Kroemer, 2001; Guicciardi et al., 2004) . However, the precise lysosomal pathway in ER stress-induced apoptosis remains unclear. Apoptotic stimuli cause lysosomal membrane permeabilization (LMP) through a variety of regulatory factors, such as calcium, reactive oxygen species, ceramide, sphingosine, phospholipase, Bax, Bim, Bid, and caspase Kroemer and Jaattela, 2005) . The lysosomal proteolytic enzymes, mainly proteases of the cathepsin family, translocate to the cytosol. Once in the cytosol, cathepsin B and cathepsin D are the major mediators triggering apoptotic pathways, which involve Bid truncation, caspase activation, and mitochondrial damage (Chwieralski et al., 2006) . Under ER stress, both lysosomal and mitochondrial destabilization may contribute to the initiation stage of apoptosis.
Glycogen synthase kinase (GSK)-3␤, a serine/threonine kinase, has multifactorial roles for controlling cell proliferation, differentiation, motility, inflammation, and apoptosis (Jope and Johnson, 2004) . Overexpression of GSK-3␤ or blockage of phosphatidylinositol 3-kinase/Akt, the negative regulator of GSK-3␤, causes apoptosis (Pap and Cooper, 1998) . GSK-3␤ is also involved in ER stress-induced apoptosis (Chen et al., 2004; Brewster et al., 2006) ; however, the exact downstream targets of GSK-3␤ remain inconclusive. GSK-3␤ can phosphorylate Bax and cause its conformational change (Linseman et al., 2004) . In growth factor withdrawalinduced apoptosis, GSK-3␤ causes Mcl-1 phosphorylation followed by degradation via an ubiquitin-proteasome system (Maurer et al., 2006) . Current studies show that caspase-2 mediates proapoptotic Bax and Bid activation during genotoxic stimulation and ER stress, respectively (Cao et al., 2008; Upton et al., 2008) . We previously showed that GSK-3␤ is essential for ceramide-and etoposide-induced caspase-2 activation before mitochondrial apoptosis (Lin et al., 2007) . In the present study, we found an essential role of GSK-3␤ in ER stress-induced lysosomal apoptosis. GSK-3␤ regulated initial caspase-2 activation upstream of lysosomal destabilization but was mitochondria independent. Furthermore, lysosomal cathepsin B-mediated caspase-8 and -3 activation was demonstrated.
Materials and Methods
Cell Culture and Reagents. Human monocytic leukemia/lymphoma U937, acute myeloid leukemia HL-60, and chronic myeloid leukemia K562 cells were cultured in RPMI 1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine serum and maintained at 37°C in 5% CO 2 . Ceramide analog C 2 -ceramide (BIOMOL Research Laboratories, Plymouth Meeting, PA), tunicamycin, Z-FA-fmk, Isovalery-Val-Val-Sta-Ala-Sta (pepstatin A), SB415286, and LY294002 (Sigma-Aldrich, St. Louis, MO) were dissolved in dimethyl sulfoxide (DMSO). 4,6-Diamidino-2-phenylindole (DAPI), propidium iodide (PI), and acridine orange (AO) were purchased from Sigma-Aldrich. Caspase-2 inhibitor Z-VDVADfmk, caspase-3 inhibitor N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone, caspase-4 inhibitor Z-Leu-Glu(Ome)-ValAsp(Ome)-fluoromethyl ketone, caspase-8 inhibitor Z-IETD-fmk, caspase-9 inhibitor N-benzyloxycarbonyl-Leu-Glu-His-Asp-fluoromethyl ketone, and broad-spectrum caspase inhibitor Z-VAD-fmk were dissolved in DMSO and purchased from Sigma-Aldrich.
Western Blotting. To detect indicated proteins, total cell lysates were extracted using a Triton X-100-based lysis buffer [1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.5, 5 mM EDTA, 5 mM NaN 3 , 10 mM NaF, and 10 mM sodium pyrophosphate with a protease inhibitor mix and a phosphatase inhibitor cocktail I (Sigma-Aldrich)]. Proteins were separated using SDS-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene difluoride membrane (Millipore Corporation, Billerica, MA). After blocking, blots were developed with a series of antibodies as indicated. Antibodies specific for caspase-2, -8, and -9 and GRP78, GSK-3␤, and phospho-GSK-3␤ (Ser9) were purchased from Cell Signaling Technology Inc. (Danvers, MA); antibodies specific for caspase-3, CHOP, and phospho-GSK-3␤ (Tyr216) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); and antibodies against caspase-4 and ␤-actin were from Sigma-Aldrich. Finally, blots were hybridized with horseradish peroxidase-conjugated goat anti-rabbit IgG or anti-mouse IgG (Cell Signaling Technology Inc.) and developed using an ECL Western blot detection kit (Millipore Corporation) according to the manufacturer's instructions.
Analysis of Apoptosis. For apoptosis detection, cells were fixed with 70% ethanol in phosphate-buffered saline (PBS) for PI staining and then were analyzed using flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA). Apoptotic cell membrane disruption characterized by the presence of phosphatidylserine was performed using an annexin V-fluorescein isothiocyanate detection kit (BioVision, Mountain View, CA), followed by flow cytometric analysis and fluorescence microscopic observation (BX51; Olympus, Tokyo, Japan). DAPI and Hoechst 33342 dye were used for nuclear staining.
Analysis of Caspase Activity. For the detection of caspase-2 activation, a caspase-2 colorimetric assay kit (Millipore Bioscience Research, Temecula, CA) was used according to the manufacturer's instructions. Optical density measurements were performed using a Fluorskan Ascent fluorescence microplate reader (Thermo Fisher Scientific, Waltham, MA).
Short Interfering RNA and Plasmid Transfection. The short interfering RNAs (siRNAs) specific for human caspase-2 and GSK-3␤ were purchased from Santa Cruz Biotechnology, Inc. The pcDNA 3.1 constructs expressing a constitutively active form of GSK-3␤ (S9A) was a gift from Dr. P. J. Lu (Institute of Clinical Medicine, National Cheng Kung University Medical College, Taiwan). Transient transfection was performed using an MP-100 Microporator (Digital Biotechnology, Seoul, Korea) according to the manufacturer's instructions for optimization and usage. After transfection, the cells were cultured for 24 h before the experiments.
Assay of LMP. Cell cultures were vitally stained with AO at a concentration of 5 g/ml for 15 min and then washed with PBS. AO is a lysosomotropic weak base and a concentration-dependent metachromatic fluorophore. AO relocation from lysosomes to cytosol, and the decrease of granular (lysosomal) red fluorescence (dimer form) in jpet.aspetjournals.org combination with the increased diffuse (cytosolic and nuclei) green fluorescence (monomer form) may imply the deterioration of lysosomal membrane stability with a decreased proton gradient, which permits the leakage of the lysosomal contents to cytosol. The levels of LMP were analyzed using flow cytometry (FACSCalibur) with excitation set at 488 nm (FL-3). In addition, the relative intensities of red and green fluorescence were simultaneously examined using fluorescence microscopy (BX51).
Immunostaining. For intracellular immunostaining, cells were fixed and permeabilized with 4% formaldehyde in PBS for 10 min at room temperature. After the cells were washed, anti-cathepsin B antibody (Calbiochem, San Diego, CA) was used followed by FITCconjugated secondary antibody (BioVision) staining. DAPI was used for nuclear staining.
Statistical Analysis. Values are as means Ϯ S.D. Groups were compared using Student's two-tailed unpaired t test or one-way analysis of variance analysis. Statistical significance was set at p Ͻ 0.05.
Results

Tunicamycin Induced ER Stress and Apoptosis in Leukemia.
To investigate the mechanism of ER stress-induced apoptosis in leukemia, human monocytic leukemia/ lymphoma U937 was used. Using Western blot analysis, we confirmed that tunicamycin increased the expression of chaperone proteins GRP78 and CHOP time-dependently (Fig.  1A ). Treating cells with tunicamycin showed apoptotic phenomena, including membrane blebbing and DNA condensation and fragmentation (data not shown). In addition, annexin V staining demonstrated tunicamycin-induced apoptosis characterized by phosphatidylserine externalization (data not shown). Cell necrosis was also observed using annexin V plus PI staining. We further tested the effects of tunicamycin on other leukemia cell lines by using PI staining and flow cytometric analysis. The results showed that tunicamycin induced apoptosis in U937 cells and human acute myeloid leukemia HL-60 cells but not in chronic myeloid leukemia K562 cells (Fig. 1B) .
Tunicamycin Induced Caspase-2-Regulated Caspase-8 and -3 Activation and Apoptosis. To verify the role of caspases in ER stress-induced leukemia apoptosis, we used Western blot analysis to clarify the time kinetic activation of caspases in tunicamycin-treated U937 cells. Results showed that caspase-2, -3, -4, and -8 were activated within 6 h, whereas caspase-9 was slowly activated ( Fig. 2A ). An increase in caspase-2 activity after tunicamycin treatment was further demonstrated (Fig. 2B ). Pharmacological inhibition of caspases revealed the requirement of caspase-2, -3, -4, and -8, but not caspase-9, in tunicamycin-induced apoptosis (Fig. 2C) . It is notable that inhibiting caspase-2 with Z-VDVAD-fmk blocked activation of caspase-8 and -3 but not caspase-4 (Fig. 2D ). Caspase-8 inhibitor Z-IETD-fmk also inhibited caspase-8 and -3 but not caspase-4. Further studies using caspase-2 siRNA showed a reduction in tunicamycininduced apoptosis (Fig. 2E) . These results suggest a sequential activation of caspase-2, -8, and -3 for tunicamycin-induced apoptosis in U937 cells, whereas caspase-4 plays a parallel role. To examine the possible mechanism of caspase-4, we found that calpain inhibitor MDL28170 partially reduced tunicamycin-induced apoptosis (Supplemental Fig. S1A ) and activation of caspase-4, but not caspase-2, -8, and -3 (Supplemental Fig. S1B ).
Tunicamycin Induced LMP and Apoptosis. ER stress has been widely reported to be associated with mitochondrial membrane permeabilization followed by apoptosis. To further investigate whether the mitochondrial pathway is involved in ER stress-induced U937 cell apoptosis, we found that tunicamycin caused only slight reduction of mitochondrial transmembrane potential as detected by lipophilic cationic fluorochrome rhodamine 123 staining, when hydrogen peroxide treatment was used as a positive control (Supplemental Fig. S2A ). Furthermore, the mitochondrial permeability transition pore stabilizers, bongkrekic acid and cyclosporine A, could not block tunicamycin-induced apoptosis and caspase-4 and -3 activation (Supplemental Fig. S2B ). In addition, the expression of the proapoptotic protein Bax (Supplemental Fig. S2C ) and the antiapoptotic proteins Bcl-2 and Bcl-xL (Supplemental Fig. S2D ) were not significantly altered upon tunicamycin treatment. These results, together with the finding that caspase-9 inhibitor did not cause an effect on apoptosis (Fig. 2C) , indicated the independence of a mitochondrial pathway in tunicamycin-induced U937 cell apoptosis.
We next asked whether the lysosome-related pathway is involved in tunicamycin-induced apoptosis. Using a metachromatic fluorophore AO staining, we found that acidic compartments within cells (i.e., lysosomes) were stained in dense brown dots (bright field) or dense red dots (blue fluorescence excitation), whereas tunicamycin treatment caused dye diffusion and loss of dotted architecture. Flow cytometric analysis showed an induction of LMP after tunicamycin treatment (Fig. 3A) . Meanwhile, cytosolic acidification was also observed (Supplemental Fig. S3 ). To further study the mechanism of lysosomal apoptosis, the lysosomal protease inhibitors, Z-FA-fmk (a cathepsin B inhibitor) and pepstatin A (a cathepsin D inhibitor), were used. We found that only Z-FAfmk but not pepstatin A inhibited tunicamycin-induced apoptosis (Fig. 3B) . In tunicamycin-treated cells, either cathepsin B (Fig. 3C ) or cathepsin D (data not shown) was released from the lysosomes (punctate signals) to the cytosol (diffused signals). Taken together, these data suggested ER stress may cause lysosomal destabilization and cathepsins relocation followed by cathepsin B-regulated U937 cell apoptosis. 
Downloaded from
Caspase-2 Acted Upstream of Tunicamycin-Induced LMP followed by Caspase-8 and -3 Activation. To further investigate the cross-talk between caspases and lysosomal protease cathepsin B, we found that Z-FA-fmk inhibited tunicamycin-induced caspase-8 and -3 but not caspase-2 and -4 activation (Fig. 4A) . Because caspase-2 activation was not inhibited by Z-FA-fmk, we then examined the possibility that caspase-2 may act upstream of lysosomal destabilization. Both caspase-2 inhibitor Z-VDVAD-fmk and pan-caspase inhibitor Z-VAD-fmk reduced tunicamycin-triggered LMP (Fig.  4B ) and cathepsin B relocation (Fig. 4C) . We further used caspase-2 siRNA and demonstrated that inhibiting caspase-2 reduced tunicamycin-induced LMP (Fig. 4D) . Therefore, these results indicated that caspase-2 acted upstream of lysosomal destabilization in tunicamycin-induced apoptotic pathway.
GSK-3␤ Mediated Tunicamycin-Induced Caspase-2 Activation and Lysosomal Apoptosis. Upon tunicamycin treatment, there was a time-dependent activation of GSK-3␤, which was represented by its dephosphorylation at Ser9 and phosphorylation at Tyr216 (Fig. 5A ). Treating U937 (Fig.  5B) , and HL-60 (Supplemental Fig. 4A ) cells with the GSK-3␤ inhibitor SB415286 showed a marked decrease in tunicamycin-induced apoptosis. The ER stressor brefeldin A, an inhibitor of protein transportation from ER to Golgi, consistently induced GSK-3␤-dependent apoptosis in U937 cells (Supplemental Fig. S4B ). Furthermore, GSK-3␤ siRNA inhibited tunicamycin-induced U937 cell apoptosis (Fig. 5C ). In addition, tunicamycin-induced activation of caspase-2, -8, and -3, but not caspase-4, were inhibited by SB415286 (Fig.  5D ). Further studies using GSK-3␤ siRNA showed a reduction in tunicamycin-induced caspase-2 activation (Fig. 5E) . We also demonstrated that SB415286 comprehensively reduced LMP and cathepsin B relocation (Fig. 5F ). These results revealed that GSK-3␤ acted upstream of caspase-2 to regulate ER stress-induced lysosomal apoptosis.
Activating GSK-3␤ Sensitized ER Stress-Resistant K562 Cells to Undergo Apoptosis. As shown in Fig. 1D , . D, U937 cells were treated with tunicamycin for 24 h with or without Z-VDVAD-fmk or Z-IETD-fmk, and the activation of caspase-3, -4, and -8 was determined by Western blot. ␤-Actin was the internal control. E, in caspase-2 siRNA-transfected and control cells, the expression of caspase-2 was detected by Western blot (left). ␤-Actin was the internal control. Cell apoptosis after tunicamycin treatment for 24 h was detected using PI staining followed by flow cytometric analysis (right). The percentages of apoptotic cells are shown (means Ϯ S.D. of triplicate cultures; ‫,ءء‬ p Ͻ 0.01 compared with the tunicamycin-alone group).
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org Downloaded from K562 cells were resistant to tunicamycin-induced apoptosis. To further explore its possible mechanism, we first confirmed that, consistent with the absence of apoptotic cell death, there was only basal level of LMP in K562 cells (Fig. 6A) . Western blot analysis demonstrated only slight GRP78 induction and no GSK-3␤ Ser9 dephosphorylation or caspase-2 activation (Fig. 6A ). U937 and HL-60 cells were used as the positive controls. Likewise, antiacute myeloid leukemia agents, cytarabine and idarubicin, did not induce LMP and apoptosis and GRP78 (Supplemental Fig. S5 ) in K562 cells. To overcome the apoptosis-resistant characteristics, three strategies were conducted to cause GSK-3␤ activation in K562 cells, which included treating cells with the PI 3-kinase inhibitor LY294002, the active form of GSK-3␤, and ceramide, a tumor suppressor lipid and activator of GSK-3␤ (Lin et al., 2007) . Results showed that drug treatment alone can sensitize K562 cells to undergo apoptosis and LMP induction, whereas tunicamycin further enhanced these effects (Fig. 6,  B and C) .
Discussion
In the present study, we demonstrate that ER stress induces higher UPR, followed by GSK-3␤ activation, and triggers caspase-2-mediated LMP, cathepsin B relocation, and caspase-8 and -3 activation, leading to apoptosis in U937 and HL-60 cells. However, K562 cells show an apoptosis-resistant phenotype by which there is a deficiency in ER stress-induced UPR and GSK-3␤ activation. The proposed signaling pathway is summarized (Fig. 6D) . These results not only suggest ER as a potential target of antileukemic therapy but also provide an alternative candidate, GSK-3␤, for treating cells exhibiting apoptosis resistance.
Although ER stress is involved in antileukemic agent-induced apoptosis (Du et al., 2006; Rahmani et al., 2007) , the mechanisms are not well defined because of the discrepancy between different ER stressor stimulation and different UPRs in various cell types. Herein, we demonstrate the apoptotic effects of tunicamycin, an ER stressor, on U937 and HL-60 but Fig. 3 . Tunicamycin induced LMP and cathepsin B relocation. U937 cells were treated with tunicamycin (2 g/ml) for 24 h. A, using AO staining followed by fluorescence microscopic observation (phase-contrast channel or FL1 plus FL2 channels) (top and middle) and flow cytometric analysis (bottom), the induction of LMP is shown. Cells with diffused brown color (black arrowheads) or red fluorescence (white arrowheads) are indicated for LMP. Scale bar, 20 m. For flow cytometric analysis, the histogram, and the percentages of cells with LMP are shown (means Ϯ S.D. of triplicate cultures). B, with or without 50 M cathepsin B inhibitor (Z-FA-fmk) or 10 g/ml cathepsin D inhibitor (pepstatin A), apoptosis was detected using PI staining followed by flow cytometric analysis. The percentages of apoptotic cells are shown (means Ϯ S.D. of triplicate cultures). C, before tunicamycin treatment, U937 cells were prestimulated with 20 ng/ml phorbol 12-myristate 13-acetate for 40 h to allow cell attachment. Expression of cathepsin B was detected using immunostaining followed by fluorescence microscopic observation. DAPI was used for nuclear staining. Scale bar, 20 m. not K562 cells. We further showed that antimetabolic agent cytarabine and anthracycline idarubicin, both antileukemic agents in treating acute myeloid leukemia, also caused significant UPR, LMP, and apoptosis in U937 and HL-60, but not in K562 cells. The present study, together with previous reports (Lotfi et al., 2002) , indicate that K562 cells exhibit an apoptosisresistant phenotype. Furthermore, in addition to the previously described mechanisms, including the difference in drug metabolism (Lotfi et al., 2002) and in Bcl-2 synthesis (Durrieu et al., 1999) , we found a novel mechanism that the failure of UPR induction by tunicamycin and antileukemic agents may cause the apoptosis-resistant phenotype of K562 cells.
Apoptosis is generally associated with dysregulation in ER, lysosome, and mitochondria (Ferri and Kroemer, 2001 ). The involvement of mitochondrial pathway in ER stress-induced cell death has been well addressed (Breckenridge et al., 2003) . In addition, caspase-2-mediated Bid activation is involved in ER stress-induced mitochondrial permeabilization (Upton et al., 2008) . Our results showed that caspase-9, a general caspase activated after mitochondrial pathway, was activated only in the late stage of tunicamycin treatment. At the early stage, the involvement of the mitochondrial pathway was excluded; instead, the essential role of lysosomal pathway was demonstrated. The lysosome is also a cellular target for treating cancer (Linder and Shoshan, 2005) . The present study showed that tunicamycin induced cellular acidification and apoptosis after the induction of LMP in leukemia. Consistent with previous studies (Cheung et al., 2006; Upton et al., 2008) , we also found that caspase-2 plays an important role for triggering apoptotic signaling in response to ER stress. Nevertheless, the downstream effects of caspase-2 are diverse. Caspase-2 is able to regulate Bax and Bid activation (Cao et al., 2008; Upton et al., 2008) . Although Bax and Bid are involved in LMP as demonstrated previously, using Bax-inhibiting peptide-V5, our data showed inhibiting Bax did not prevent tunicamycin-induced lysosomal destabilization and apoptosis (data not shown).
Caspase-8 has been demonstrated to cause LMP (Guicciardi et al., 2000; Werneburg et al., 2004) . Our results showed that caspase-8 acts downstream of caspase-2-mediated LMP. Furthermore, ceramide, reactive oxygen species, calcium, and phospholipase A2, which had been demonstrated to be involved in the induction of LMP and apoptosis Kroemer and Jaattela, 2005) , were excluded in tunicamycininduced U937 cell apoptosis (data not shown). Based on these findings, we hypothesize that caspase-2 is involved in triggering a lysosomal pathway. How caspase-2 induces lysosomal destabilization requires further investigation.
The mechanisms of ER stress-induced caspase cascade acti- . Tunicamycin induced GSK-3␤ activation and GSK-3␤-dependent caspase-2 activation and lysosomal apoptosis. A, U937 cells were treated with tunicamycin (2 g/ml) for various time periods, and phosphorylation levels of GSK-3␤ at Ser9 or Tyr216 and total GSK-3␤ were determined by Western blot. ␤-actin was the internal control. B, U937 cells were treated with tunicamycin for 24 h with or without 25 M GSK-3␤ inhibitor (SB415286) followed by DAPI and PI staining followed by fluorescence microscopic observation and flow cytometric analysis, respectively. The percentages of apoptotic cells are shown (means Ϯ S.D. of triplicate cultures). Scale bar, 40 m. C, in GSK-3␤ siRNA-transfected and control cells, the expression of GSK-3␤ was detected by Western blot (left). ␤-Actin was the internal control. Cell apoptosis after tunicamycin treatment for 24 h was detected using annexin V or PI staining, followed by flow cytometric analysis (right). The percentages of apoptotic cells are shown (means Ϯ S.D. of triplicate cultures; ‫,ءء‬ p Ͻ 0.01 compared with the tunicamycin-alone group). D, with or without SB415286, tunicamycin-induced activation of caspase-4, -2, -8, and -3 was detected by Western blot. ␤-actin was the internal control. (E) In GSK-3␤ siRNA-transfected cells, caspase-2 activation after tunicamycin treatment for 24 h was detected by Western blot. ␤-Actin was the internal control. F, with or without SB415286, tunicamycin-induced LMP was detected by AO staining followed by flow cytometric analysis. The histogram and the percentages of cells with LMP are shown (means Ϯ S.D. of triplicate cultures) (top). Using immunostaining (bottom), expression of cathepsin B was detected in U937 cells prestimulated with 20 ng/ml phorbol 12-myristate 13-acetate for 40 h to allow cell attachment before tunicamycin treatment. DAPI was used for nuclear staining. Scale bar, 20 m.
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org vation are multimodal. We showed that tunicamycin-induced U937 cell apoptosis is partially calpain-and caspase-4-dependent. We further demonstrated that tunicamycin induced caspase-2-mediated sequential activation of caspase-8 and -3 after lysosomal cathepsin B release from lysosomes to the cytosol. Caspase-8 can be activated via various ways, including recruitment of death-inducing signaling complex, overloading of calcium, and activation of calpain and cathepsins (Boatright and Salvesen, 2003) . It has been reported that cathepsin B activates capsase-2 and cathepsin D activates caspase-8 Conus et al., 2008) . However, our data showed the ability of cathepsin B to regulate activation of caspase-8 but not caspase-2. These results also indicated an essential role of caspase-2 for lysosomal pathway of apoptosis in U937 cells. The mechanism of caspase-2 activation after ER stress remains to be investigated. GSK-3␤ is implicated in ER stress-induced apoptosis (Chen et al., 2004; Brewster et al., 2006) ; however, the mechanism is still unresolved. This study is the first to show that GSK-3␤ and caspase-2 mediate ER stress-induced leukemia apoptosis through the induction of a lysosomal pathway, which involves LMP, cathepsin B release, and caspase-8 activation. Although GSK-3␤ can directly activate Bax (Linseman et al., 2004) , our results showed the independence of Bax in tunicamycin-induced LMP and apoptosis (data not shown). It is not yet clear which mechanism leads to activation of caspase-2 in tunicamycin-treated U937 cells. Speculation includes the interaction of receptor-interacting protein-associated ICH-1/CED-3 homologous death protein with a death domain and the formation of PIDDosome, the complex of p53-induced protein with a death domain, receptorinteracting protein-associated ICH-1/CED-3 homologous death protein with a death domain, and caspase-2 (Tinel and Tschopp, 2004) . Because p53 has been reported to be partially involved in ER stress-induced apoptosis , it is interesting to investigate whether p53 is involved in tunicamycin-induced U937 apoptosis. Furthermore, a mechanism has been proposed by which human inhibitor of apoptosis 2 (HIAP2) can negatively regulate ER-initiated apoptosis by inhibiting caspase-2 (Cheung et al., 2006) . In ER stress, HIAP2 is up-regulated by an inducible internal ribosome entry site element (Warnakulasuriyarachchi et al., 2004) . In tunicamycin-treated U937 cells, the expression and regulation of HIAP2 needs further study. Our data herein demonstrate that the activation of caspase-2 is positively regulated by GSK-3␤. A similar finding also has been demonstrated in our previous studies concerning the mechanism of ceramide-induced apoptosis (Lin et al., 2007) .
The mechanisms of GSK-3␤ activation under ER stress are still largely unknown. GSK-3␤ is generally inhibited by serine phosphorylation, mainly through PI 3-kinase/Akt pathway and also through several kinases, including mitogen-activated protein kinase-activated protein kinase-1 (also known as p90rsk), p70 ribosomal S6 kinase, protein kinase A, protein kinase C, extracellular signal-regulated kinase, and Wnt signaling (Jope and Johnson, 2004) . Protein phosphatase 2A (PP2A) activation may concomitantly dephosphorylate and activate GSK-3␤ directly or indirectly by dephosphorylating Akt (Ivaska et al., 2002) . Furthermore, GSK-3␤ is positively regulated by tyrosine phosphorylation through Pyk2, mitogen-activated protein kinase kinase, and Src-like kinase (Jope and Johnson, 2004) . However, our unpublished data showed that GSK-3␤ was acti- Fig. 6 . Activating GSK-3␤ sensitized ER stress-resistant K562 cells to undergo apoptosis. A, U937, HL-60, and K562 cells were treated with tunicamycin for 48 h. The induction of LMP and apoptosis was detected using AO and PI staining, respectively, followed by flow cytometric analysis. The percentages of cells with LMP (white column) and apoptosis (black column) are shown (means Ϯ S.D. of triplicate cultures) (top). Meanwhile, expression of GRP78, phosphorylated GSK-3␤ Ser9, and total GSK-3␤ and activation of caspase-2 was detected by Western blot (bottom). ␤-Actin was the internal control. B and C, with or without LY294002, active GSK-3␤ (S9A), or ceramide cotreatment for 72 h, tunicamycin-induced K562 cells were tested for the induction of apoptosis and LMP using PI (black column) and AO (white column) staining, respectively, followed by flow cytometric analysis. The percentages of apoptotic cells and cells with LMP are shown (means Ϯ S.D. of triplicate cultures). D, hypothetical model of ER stress-induced GSK-3␤-and caspase-2-dependent lysosomal pathway of apoptosis. vated independently of Akt-down-regulated, PP2A-mediated, and tyrosine kinase-regulated pathways (data not shown). This is inconsistent with a previous report (Chen et al., 2004) showing that dephosphorylation of Akt and activation of PP2A were associated with ER stress-induced GSK-3␤ activation and apoptosis. Heat shock protein 90 actually was demonstrated previously to regulate the activity of GSK-3␤ (Lochhead et al., 2006) . Our data show that the heat shock protein 90 inhibitor 17-AAG reduces tunicamycin-induced apoptosis, LMP, and caspase-2, -8, and -3 activation (Supplemental Fig. S6 ). Current studies show that ER stress-activated chaperon proteins GRP78 and heat shock protein 105 are involved in caspase-3 activation (Meares et al., 2008) ; therefore, the potential role of these proteins in ER stress-induced GSK-3␤ activation needs to be considered.
The inactivation of GSK-3␤ has been reported to be involved in oncogenesis and the progression of drug-resistant phenotype (Ding et al., 2007) . Here, we show that GSK-3␤ and caspase-2 are unable to be activated in K562 cells, whereas UPR also fails to be induced. Thus, we hypothesize that these events cause an apoptosis-resistant phenotype in K562 cells. Compared with the signaling pathways in U937 and HL-60 cells, it became evident that GSK-3␤ acts as an apoptosis-promoting target. In accordance, we demonstrated that activating GSK-3␤ by exogenous treatment with LY294002, active form of GSK-3␤, or ceramide, caused K562 cells to be vulnerable for LMP and apoptosis. This is consistent with previous studies on antihepatoma therapy (Beurel et al., 2005) . For antileukemic therapy, our present findings implicate the involvement of GSK-3␤-regulated lysosomal pathway in ER stress-induced apoptosis. 
